SUB : AI Subtitles Service
KOR : Session in Korean
| Date/Time | Room 1 | Room 2 | Room 3 | Room 4 |
|---|---|---|---|---|
| Vista 1 (B2) | Vista 2 (B2) | Grand Hall (B1) | Art Hall (4F) | |
| 08:50-09:00 | Opening Remark | |||
| 09:00-10:30 |
Joint Session 01 (EHA–KSH) Re-engineering Immunotherapy in Lymphoma: From Next-Generation Platforms to Rational Sequencing |
Scientific Session 01 Rethinking Frontline AML Therapy: Beyond the Fit–Unfit Paradigm |
Laboratory Medicine Update in Hematology |
Education Session 01 Immune and chemotherapy induced cytopenias: Addressing challenges and advancing treatments
SUB
|
| 10:30-10:45 | Break | |||
| 10:45-11:30 | Plenary Lecture 01 Core-Binding Factors in Hematopoietic Stem Cell Ontogeny and Leukemia | |||
| 11:30-12:15 | Presidential Symposium Extending the Reach of Immune Effector Cell Therapies | |||
| 12:15-12:30 | Break | |||
| 12:30-13:20 | Luncheon Symposium 01 | Luncheon Symposium 02 | Luncheon Symposium 03 | Luncheon Symposium 04 |
| 13:20-14:10 | Poster Viewing 1 (Walker Hall, 1F) | |||
| 14:10-15:40 |
Scientific Session 02 Rational Combinations in Myelofibrosis: Building on the JAK-Inhibitor Backbone |
Scientific Session 03 Changing Paradigms in Pediatric Hematology |
Scientific Session 04 Beyond Haploidentical: Expanding the PTCy Platform and Novel Therapeutics for GVHD |
Education Session 02 The Evolving Role of Laboratory Hematology in Precision Medicine
SUB
|
| 15:40-15:50 | ||||
| 15:50-15:55 | Break | |||
| 15:55-16:55 | Oral Presentation 01 | Oral Presentation 02 | Oral Presentation 03 | Oral Presentation 04 |
| 16:55-17:05 | Break | |||
| 17:05-18:05 | Oral Presentation 05 | Oral Presentation 06 | Oral Presentation 07 | Oral Presentation 08 |
| 18:05-18:40 | Break | |||
| 18:40~ | Welcome Reception (Aston House) | |||
| Date/Time | Room 1 | Room 2 | Room 3 | Room 4 |
|---|---|---|---|---|
| Vista 1 (B2) | Vista 2 (B2) | Grand Hall (B1) | Art Hall (4F) | |
| 09:00-10:30 |
Joint Session 02 (Asia & MOU Session) Advances in Immunotherapy for Childhood ALL in Asian Countries |
Scientific Session 05 Understanding of Diagnosis and Therapy in Hemophilia |
Scientific Session 06 AI-Driven Breakthroughs in Precision Hematology: From Single-Cell Dynamics to Clinical Practice |
Education Session 03 Rare Hematology Across the Age Boundary
KOR
SUB
|
| 10:30-10:45 | Break | |||
| 10:45-11:30 | Plenary Lecture 02 CAR T-Cell Therapy in Hematologic Malignancies and Beyond | |||
| 11:30-12:20 | Poster Viewing 2 (Walker Hall, 1F) | |||
| 12:20-12:30 | Break | |||
| 12:30-13:20 | Luncheon Symposium 05 | Luncheon Symposium 06 | Luncheon Symposium 07 | Luncheon Symposium 08 |
| 13:20-13:35 | Break | |||
| 13:35-14:35 | Oral Presentation 09 | Oral Presentation 10 | Oral Presentation 11 | Oral Presentation 12 |
| 14:35-14:45 | Break | |||
| 14:45-16:15 |
Joint Session 03 (ASH-KSH) Precision Medicine in Aplastic Anemia and PNH: Translating Biology into Better Care |
Scientific Session 07 In Vivo CAR-T and Next-Generation Cell Engineering |
Scientific Session 08 Emerging Challenges and Precision approaches in Transfusion Medicine |
Education Session 04
How I treat: Indolent and peripheral T-cell lymphomas
KOR
SUB
|
| 16:15-16:30 | Break | |||
| 16:30-18:00 |
Scientific Session 09 Chemotherapy-sparing, immunotherapy-driven frontline ALL |
Scientific Session 10 Clonal Hematopoiesis and Myeloid Neoplasms: Biology, Risk, and Clinical Implications |
Education Session 05 Optimizing Novel Immunotherapies in RR MM
SUB
|
|
| 18:00-18:30 | Break | |||
| 18:30~ | Gala Dinner (Vista 1+2) | |||
| Date/Time | Room 1 | Room 2 | Room 3 | Room 4 |
|---|---|---|---|---|
| Vista 1 (B2) | Vista 2 (B2) | Grand Hall (B1) | Art Hall (4F) | |
| 07:30-08:00 | KSH Business Meeting | |||
| 08:00-08:30 | Young Investigator Award Presentation | |||
| 08:30-09:00 | ||||
| 09:00-10:30 |
Joint Session 04 (East Asia Session) High-Risk Disease and Imaging Assessment in Multiple Myeloma |
Scientific Session 11 Navigating Modern CLL Management: From Treatment Strategies to Double-Exposed Disease |
Scientific Session 12 The Shifting Boundaries of MDS: Classification, Risk Stratification, and Emerging Targets |
Education Session 06 Beyond CRS: Emerging Challenges in CAR-T Toxicity
KOR
SUB
|
| 10:30-10:45 | Break | |||
| 10:45-11:30 | Plenary Lecture 03 New Response Criteria in Multiple Myeloma | |||
| 11:30-11:45 | Break | |||
| 11:45-12:15 | Closing Ceremony | |||
| 12:15-12:45 | KSH General Assembly | |||